Physician profile
Brandi Hermes
NPI 1689438640
$992.20
in general payments reported to CMS, 2019-2025
12 companies · $620 in 2025
The $620 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $372 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $385.58 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $188.96 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.80 | 2024-2025 | |
| Pfizer INC. | $49.20 | 2024-2025 | |
| Daiichi Sankyo INC. | $47.22 | 2025 | Injectafer |
| Lilly USA, LLC | $44.73 | 2024-2025 | Jardiance |
| Exact Sciences Corporation | $41.99 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novo Nordisk INC | $34.22 | 2024-2025 | Wegovy |
| Hologic Sales and Service, LLC | $24.82 | 2025 | Aptima |
| Amgen INC. | $21.59 | 2025 | Repatha, Otezla |
| Dexcom, INC. | $17.35 | 2024 | Dexcom G6 Transmitter |
| Intra-Sana Laboratories | $13.74 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandi Hermes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.